• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

On-Q-ity

edit

On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. There platform will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival.

Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream.

Milestones

edit

• 
  On-Q-ity added Daniel Paterson as COO.
  Posted 12/14/09 at 10:26pm
• 
  On-Q-ity added Mara Aspinall as President & CEO.
  Posted 12/14/09 at 10:26pm
• 
  On-Q-ity received $26M in Series A funding. (12/14/09)
  Posted 12/14/09 at 10:26pm via masshightech.com

Videos

Screenshots

edit

Above: Home Page
Uploaded: 12/15/09

Sources

1. On-Q-ity rounds out $26M Series A financing (masshightech.com) [edit]